Crunching the numbers on the first half drought for biotech IPOs
Bio Pharma Dive
JUNE 30, 2022
Data compiled by BioPharma Dive show a growing gap in the frequency and size of new stock offerings compared to prior years. Some analysts believe as many as a third of public biotechs must “go away” before the sector’s slump ends.
Let's personalize your content